Search research articles
Contact Us
Filters
Showing results (411-420 of 418) with videos related to
Page
of 42
Sort By:
You have reached the last page of results.
This site can display upto 418 results.
Cell Stem Cell
|
July 8, 2017
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
Kelley S Yan, Olivier Gevaert, Grace X Y Zheng, et al.
Chest
|
July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial
Wesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 26, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021
Mark W Tenforde, Wesley H Self, Eric A Naioti, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
MMWR. Morbidity and Mortality Weekly Report
|
September 23, 2021
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021
Wesley H Self, Mark W Tenforde, Jillian P Rhoads, et al.
Page
of 42
Search research articles
Search
Showing results (411-420 of 418) with videos related to
Sort By:
Page
of 42
You have reached the last page of results.
This site can display upto 418 results.
Cell Stem Cell
|
July 8, 2017
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
Kelley S Yan, Olivier Gevaert, Grace X Y Zheng, et al.
Chest
|
July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial
Wesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 26, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021
Mark W Tenforde, Wesley H Self, Eric A Naioti, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
MMWR. Morbidity and Mortality Weekly Report
|
September 23, 2021
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021
Wesley H Self, Mark W Tenforde, Jillian P Rhoads, et al.
Page
of 42